Locus Cell Co., Ltd.

NT$35.75As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6891Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR (13.80%)
Div yield —
ROE (9.81%)
Biotechnology
Beta (5Y) 2.32
PE TTM —
TSR TTM 22.85%
Mkt cap NT$7.170B
ROIC (5.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$44
24.39%
(64.28%)
Hold 11|2|6|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.00
0.99
1.10
1.17
21.38%
17.21%
35.36%
29.69%
RevenueNT$M
448.1
436.5
452.1
464.3
5.17%
1.82%
7.92%
7.41%
Peers (US$215.4M)
Cap (US$)
PE
210.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.513
0.252
0.228
EBIT/Intx
0.575
0.853
0.734
Own earn%
86.12
56.30
72.26
Sh yield%
19.63
30.56
30.10
Owners
Insiders/Inst%
10.19
56.83
Short interest%
4.51
SBC / revenue%
3.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
2–8
$1 testx
0.0
Incr. ROIC%
10